The current study has shown Mirk is enriched in spheroids made from ovarian cancer cell lines, these spheroids are composed of quiescent cells, and that each of three Mirk kinase inhibitors can kill these quiescent spheroid cells. This evidence concerns the gene DYRK1B and ovarian carcinoma.